收获健康:认知障碍治疗中的植物化学物质
Sanidhya Jain1, Avijit Mazumder1, Saumya Das1
1Department of Pharmacology, Noida Institute of Engineering and Technology (Pharmacy Institute), Plot No.19, Knowledge Park-II, Greater Noida, 201306, U.P., India.
Central nervous system agents in medicinal chemistry
|June 16, 2024
概括
轻度认知障碍 (MCI) 影响的是老年人,记忆力下降始于成年早期. 这项研究检查了药用草药和植物化学物质的潜力,以减少认知衰退和保护大脑.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 老年学是一门学科.
背景情况:
- 轻度认知障碍 (MCI) 在老年人群中越来越令人担忧.
- 认知能力下降会影响记忆,感知和语言,受遗传学,饮食和新陈代谢的影响.
- 药用植物中的植物化学物质由于其抗炎和抗氧化特性,在对抗认知恶化方面表现有前途.
研究的目的:
- 检查药草中植物化学物质对认知衰退的神经保护作用.
- 研究特定植物化学物质在维持大脑健康和认知功能的作用.
主要方法:
- 历史医学传统和科学文献的综述.
- 在药用草药中识别神经保护性植物化学物质 (脂肪酸,,类,黄,黄类,沙素,类).
- 对临床上可证明对认知衰退的影响的证据分析.
主要成果:
- 植物化学物质调节神经递质受体,帮助大脑的化学平衡.
- 药用植物在治疗认知障碍方面有着悠久的历史.
- 特定的植物化学物质表现出抗炎和自由基清除活动.
结论:
- 药用草药含有具有神经保护潜力的有价值的植物化学物质.
- 对这些植物化学物质的进一步研究可能会导致对认知衰退的新治疗方法.
- 植物化学物质为管理和减轻与年龄相关的认知障碍提供了一个有希望的途径.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Cognitive Development During Adulthood
88
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
88
Role of Neurotransmitters in Memory
521
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
521
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110


